Gregory Russotti

Technik-/Wissenschafts-/F&E-Leiter bei CENTURY THERAPEUTICS, INC.

Vermögen: 1 Mio $ am 31.05.2024

57 Jahre

Health Technology

Consumer Services

Finance

Aktive Positionen von Gregory Russotti

Unternehmen	Position	Beginn	Ende
CENTURY THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2020	-
	Vorstandsvorsitzender	11.04.2023	04.12.2023
	Präsident	11.04.2023	04.12.2023
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Berater	-	-

Unternehmen	Position	Beginn	Ende
CELGENE	Corporate Officer/Principal	01.10.2017	31.12.2019

Rensselaer Polytechnic Institute	Graduate Degree
Rutgers State University of New Jersey	Doctorate Degree

International

Vereinigte Staaten	5
Frankreich	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
CENTURY THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Finance

Private Unternehmen

Health Technology

Finance